Cohort and prospective studies have shown that the concentration of NLRP3 inflammasome, IL-1β, and IL-18 is increased in the atheromas and monocytes of the peripheral blood of patients with CAD and especially those with acute coronary syndromes (ACS) when compared to the control groups [30,31]. This evidence concerns the gene NLRP3 and coronary artery disorder.